Results 251 to 260 of about 19,152,486 (344)

Efficacy of interventions for myopia control in children: A systematic review with network meta‐analyses

open access: yesActa Ophthalmologica, EarlyView.
Abstract To determine the effectiveness of various interventions in reducing myopia progression in children. Literature databases were searched on December 2, 2023: PubMed, Embase, the Cochrane Central, Web of Science Core Collection, BIOSIS Previews, Current Contents Connect, Data Citation Index, Derwent Innovations Index, KCI‐Korean Journal Database,
Diana Chabané Schmidt   +9 more
wiley   +1 more source

Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

open access: yesActa Ophthalmologica, EarlyView.
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs   +12 more
wiley   +1 more source

Comparison of the effectiveness of visual acuity measurements for amblyopia screening at the age of 36 and 45 months and difference in severity of amblyopia detected

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Efficiency of visual screening using visual acuity measurement (VAM) in children screened at 45 months of age (45 m) and screened at both 36 months of age (36 m) and 45 m was investigated by determining failure, repeat and referral rates and amblyopia detection.
M. A. J. Telleman   +47 more
wiley   +1 more source

Refinement of the MYP3 locus on human chromosome 12 in a German family with Mendelian autosomal dominant high-grade myopia by SNP array mapping

open access: bronze, 2008
Frank Jacobi   +7 more
openalex   +2 more sources

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy